Education
About Us
Working with TipRanks
Follow Us
Abbott Laboratories (DE:ABL)
XETRA:ABL
Earnings Data
Report Date
Jan 28, 2026Before Open (Confirmed)
Period Ending
2025 (Q4)Consensus EPS Forecast
1.29Last Year’s EPS
1.16Same Quarter Last Year
Strong Buy
Based on 19 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The earnings call reflects a generally positive performance with strong growth in most segments, particularly in medical devices and international markets. However, challenges remain, particularly in the diagnostics market in China and impacts from tariffs.Company Guidance
Strong Organic Sales Growth
Reported organic sales growth of 7.5%, excluding COVID test sales. Growth was led by double-digit growth in medical devices and high single-digit growth in established pharmaceuticals.
Earnings Per Share Increase
Earnings per share rose to $1.30, up high single digits compared to last year and up double digits excluding the expected decline in COVID test sales.
Nutrition Segment Growth
Sales in the Nutrition segment increased by 4%, driven by 10% growth in international markets for adult nutrition products like Ensure and Glucerna.
Medical Devices Surge
Medical Devices sales grew 12.5%, with significant growth in diabetes care, electrophysiology, and cardiac rhythm management.
Strong Performance Outside China
Core Lab Diagnostics grew 7% outside of China, with markets such as the US showing an acceleration in growth.
DE:ABL Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
DE:ABL Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Oct 15, 2025 | €113.31 | €109.88 | -3.03% |
Jul 17, 2025 | €111.52 | €104.17 | -6.59% |
Apr 16, 2025 | €111.16 | €116.63 | +4.92% |
Jan 22, 2025 | €109.97 | €112.79 | +2.57% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Abbott Laboratories (DE:ABL) report earnings?
Abbott Laboratories (DE:ABL) is schdueled to report earning on Jan 28, 2026, Before Open (Confirmed).
What is Abbott Laboratories (DE:ABL) earnings time?
Abbott Laboratories (DE:ABL) earnings time is at Jan 28, 2026, Before Open (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is the P/E ratio of Abbott Laboratories stock?
The P/E ratio of Abbott Laboratories is N/A.
What is DE:ABL EPS forecast?
DE:ABL EPS forecast for the fiscal quarter 2025 (Q4) is 1.29.
